RING CHRISTINE (General Counsel) sold 6.9% of their position (3.76K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $69.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/20/2026ACC: 0001817199-26-000002
Officer· General Counsel
Since Jul 2020
-3.76K
Net shares
Net seller
$69.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.76K acquired · 7.52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.76K
Price / share
$1.86
Trade value
$6.99K
% of position
7.4%
1/20/2026
50.90K→54.66K
Common Stock
Direct
Shares
−3.76K
Price / share
$18.42
Trade value
$69.27K
% of position
6.9%
1/20/2026
54.66K→50.90K
Total
Net shares
+0.00
Net value
-$62.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/20/2026 | M · Option Exercise | +3.76K | $1.86 | $6.99K | 7.4% | 50.90K | 54.66K |
| Common Stock Direct | 1/20/2026 | S · Sale | −3.76K | $18.42 | $69.27K | 6.9% | 54.66K | 50.90K |
| Total | +0.00 | -$62.28K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
3.76K shares
Shares
−3.76K
Strike price
1.86
Held after
8.64K
Exercisable
—
1/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock3.76K shares | 1/20/2026 | M · Option Exercise | −3.76K | 1.86 | — | 8.64K |